Invention Grant
- Patent Title: Liquid formulations of daptomycin
-
Application No.: US16343443Application Date: 2017-10-17
-
Publication No.: US10933019B2Publication Date: 2021-03-02
- Inventor: Tina Gjoni , Dubravka Strazic
- Applicant: XELLIA PHARMACEUTICALS APS
- Applicant Address: DK Copenhagen
- Assignee: XELLIA PHARMACEUTICALS APS
- Current Assignee: XELLIA PHARMACEUTICALS APS
- Current Assignee Address: DK Copenhagen
- Agency: Cantor Colburn LLP
- International Application: PCT/EP2017/076519 WO 20171017
- International Announcement: WO2018/073269 WO 20180426
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K38/12 ; A61K47/18 ; A61K47/10 ; A61K47/26 ; A61K47/20 ; A61K47/14 ; A61K47/44 ; A61P31/04
Abstract:
The present invention relates to liquid pharmaceutical compositions comprising daptomycin, methods of providing such compositions and the use thereof. Provided herein are formulations comprising daptomycin, one or more polar protic solvents, and mixtures thereof. Formulations according to the present invention can further comprise polar aprotic solvent and/or source of calcium.
Public/Granted literature
- US20190240155A1 LIQUID FORMULATIONS OF DAPTOMYCIN Public/Granted day:2019-08-08
Information query
